000 01904nas a22002775i 4500
001 2047-9158
003 DE-He213
005 20260610082442.0
007 cr nn 008mamaa
008 150723s||||||||xxkuu poo|||||| b|EN |d
022 _a2047-9158
024 7 _a40035
_2local
210 1 0 _aTransl Neurodegener
245 1 0 _aTranslational Neurodegeneration
_h[electronic resource] /
_cedited by Chen Shengdi.
264 1 _aLondon :
_bBioMed Central :
_bImprint: BioMed Central.
300 _bonline resource.
520 _aTranslational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases. Topics of interest include but are not limited to the following areas of neurodegenerative diseases: Epidemiology and pathogenesis Research into diagnosis and prevention Research into the disease pathogenesis Development of new drugs and cell therapy Drug delivery Rehabilitation Translational Neurodegeneration offers the opportunity for scientists, clinicians and physician-scientists to publish their research and clinical trials in a journal which is applicable to their specific field.
650 0 _aNeurosciences.
650 0 _aNeurology .
650 1 4 _aNeuroscience.
650 2 4 _aNeurology.
700 1 _aShengdi, Chen.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
856 4 0 _uhttps://translationalneurodegeneration.biomedcentral.com/
_zOpen Access
999 _c970
_d970